Related Experiment Video
Updated: Jun 6, 2026

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Molecular imaging of the kidneys
Zsolt Szabo1, Nada Alachkar, Jinsong Xia
1Division of Nuclear Medicine, Department of Radiology, Johns Hopkins University School of Medicine, 601 N. CarolineStreet, Baltimore, MD 21287, USA. zszabo@jhmi.edu
Molecular kidney imaging uses advanced techniques like positron emission tomography for early disease detection. New radiopharmaceuticals target specific molecules to diagnose kidney injury and cancer more accurately.
Area of Science:
- Nuclear Medicine and Molecular Imaging
- Nephrology and Urology
- Oncology
Background:
- Radionuclide imaging is crucial for diagnosing kidney diseases by visualizing molecular mechanisms.
- Positron emission tomography offers quantitative imaging with high spatial resolution for renal studies.
- Increasing incidence of kidney diseases necessitates advanced diagnostic tools.
Purpose of the Study:
- To review advancements in molecular imaging for kidney disease detection and diagnosis.
- To highlight novel radiopharmaceuticals and imaging targets for renal pathophysiology.
- To discuss the potential of molecular imaging in early diagnosis and management of kidney diseases, including cancer.
Main Methods:
- Utilizing gamma cameras and positron emission tomography with various radiopharmaceuticals (e.g., H(2)(15)O, RbCl, Cu-64 labeled ligands).
- Investigating molecular targets such as angiotensin receptor subtype 1, organic anion transporters, and kidney injury molecule 1.
- Developing radioligands for organic cation transporters, peptide transporters, and monocyte chemoattractant protein-1.
Main Results:
- Radiopharmaceuticals like H(2)(15)O, RbCl, and [Cu-64] ETS are key for measuring renal blood flow.
- Molecular imaging successfully targets key pathways in renal blood flow regulation and tubular transport.
- Significant progress in detecting renal cancer using novel imaging agents and techniques like radioimmunoimaging.
Conclusions:
- Molecular kidney imaging is rapidly evolving, offering sensitive and accurate diagnostic capabilities.
- Targeting specific molecules like kidney injury molecule 1 and monocyte chemoattractant protein-1 shows promise for early detection.
- Continued development of novel imaging technologies is essential for managing the growing burden of kidney diseases.
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies VII: Vascular Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies II: Ultrasonography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies III: Computed Tomography

